Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study
- Publisher:
- Springer Nature America, Inc
- Publication Type:
- Journal Article
- Citation:
- Annals of Hematology, 2018, 97 (12), pp. 2455 - 2463
- Issue Date:
- 2018-12
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Cella-2018-Impact-of-elotuzumab-treatment-on-p.pdf | Published Version | 586.05 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Please use this identifier to cite or link to this item: